These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6813491)

  • 1. Auranofin and lysosomal enzymes.
    Finkelstein AE; Roisman FR; Ladizesky MG; Walz DT
    J Rheumatol Suppl; 1982; 8():46-53. PubMed ID: 6813491
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of two gold compounds on human polymorphonuclear leukocyte lysosomal function and phagocytosis.
    Kühn SH; Gemperli MB; De Beer FC
    Inflammation; 1985 Mar; 9(1):39-44. PubMed ID: 3920144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lysosomal enzyme release from rat leukocytes by auranofin. A new chrysotherapeutic agent.
    Dimartino MJ; Walz DT
    Inflammation; 1977 Jun; 2(2):131-42. PubMed ID: 104927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of auranofin on lymphocyte functions in vitro].
    Strejcek J; Jíra M; Horký J
    Cas Lek Cesk; 1985 Aug; 124(33):1045-7. PubMed ID: 3928163
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin)].
    Di Matteo L; D'Incecco V; Evangelista L; Castiglione C; Consoli G
    Boll Soc Ital Biol Sper; 1985 May; 61(5):777-81. PubMed ID: 3927943
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral gold therapy in rheumatoid arthritis: auranofin.
    Am J Med; 1983 Dec; 75(6A):1-164. PubMed ID: 6419590
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological evaluation in children with juvenile chronic arthritis treated with auranofin.
    Martini A; De Amici M; Visconti L; Plebani A; Fornari M; Marconi M; Panzarasa R; Astaldi A; Azzaretti G
    Int J Clin Pharmacol Res; 1985; 5(3):149-55. PubMed ID: 3926662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of rheumatoid arthritis with the oral gold preparation Auranofin].
    Trnavský K; Zbojanová M
    Cas Lek Cesk; 1982 Nov; 122(45):1382-4. PubMed ID: 6821244
    [No Abstract]   [Full Text] [Related]  

  • 11. Auranofin: more than just oral gold.
    Waller ES
    Clin Pharm; 1984; 3(2):195. PubMed ID: 6426845
    [No Abstract]   [Full Text] [Related]  

  • 12. [Auranofin].
    Ferrari M; Piro MT
    Recenti Prog Med; 1983 Aug; 74(8):968-70. PubMed ID: 6417742
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of neutrophil functions by auranofin. Studies on effects in vitro and in rheumatoid arthritis patients.
    Hafström I; Udén AM; Palmblad J
    Scand J Rheumatol; 1983; 12(2):97-105. PubMed ID: 6407101
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Therapeutic innovation in rheumatoid arthritis: worldwide auranofin symposium. Montreal, October 20-21, 1981.
    J Rheumatol Suppl; 1982; 8():1-209. PubMed ID: 6813471
    [No Abstract]   [Full Text] [Related]  

  • 15. Long term auranofin treatment in rheumatoid arthritis.
    Godfrey N; Lorber A
    J Rheumatol; 1985 Jun; 12(3):620-2. PubMed ID: 3930723
    [No Abstract]   [Full Text] [Related]  

  • 16. Auranofin in rheumatoid arthritis.
    Champion GD; Bieri D; Browne CD; Day RO; Graham GG; Haavisto TM; Sambrook PN; Vallance JB
    J Rheumatol Suppl; 1982; 8():137-45. PubMed ID: 6813475
    [No Abstract]   [Full Text] [Related]  

  • 17. Auranofin (Ridaura).
    Med Lett Drugs Ther; 1985 Oct; 27(699):89-90. PubMed ID: 3932827
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of action of auranofin: effects on humoral immune response.
    Walz DT; Dimartino MJ; Griswold DE
    J Rheumatol Suppl; 1982; 8():32-6. PubMed ID: 6813489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
    Bernhard GC
    J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.